Availability of essential medicines in Pakistan-A comprehensive document analysis.

<h4>Introduction</h4>Access to essential medicines (EMs) is a basic human right. Non-availability and shortages of EMs are reported for Pakistan but there is insufficient data to define the nature and magnitude of this problem. The current study is designed to systematically analyze the...

Full description

Saved in:
Bibliographic Details
Main Authors: Sunaina Rafi, Huma Rasheed, Muhammad Usman, Hafiz Awais Nawaz, Syed Muneeb Anjum, Mamoona Chaudhry, Zaheer-Ud-Din Babar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253880&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850239629871022080
author Sunaina Rafi
Huma Rasheed
Muhammad Usman
Hafiz Awais Nawaz
Syed Muneeb Anjum
Mamoona Chaudhry
Zaheer-Ud-Din Babar
author_facet Sunaina Rafi
Huma Rasheed
Muhammad Usman
Hafiz Awais Nawaz
Syed Muneeb Anjum
Mamoona Chaudhry
Zaheer-Ud-Din Babar
author_sort Sunaina Rafi
collection DOAJ
description <h4>Introduction</h4>Access to essential medicines (EMs) is a basic human right. Non-availability and shortages of EMs are reported for Pakistan but there is insufficient data to define the nature and magnitude of this problem. The current study is designed to systematically analyze the medicines included in the National Essential Medicines List (NEML) for their availability through comprehensive document analysis.<h4>Methods</h4>An expanded list of medicinal items was developed using the NEML of Pakistan (2018) to enlist individual medicines with their specifications. Registration status of the medicines was searched using three publicly accessible information sources; Pharmaguide 25th Edition, 2018-19, the on-line Drug Information System, and the Mobile Application Pharmapedia followed by a later 3-step validation of the data. The unregistered EMs were then further categorized into three subgroups in accordance with their possible remedial strategies.<h4>Findings</h4>The 19 studied categories comprised 690 EMs and it was found that 179 (26%) of these EMs don not have a registration status. However, it was also identified that the availability of 47 (26.2%) out of 179 unregistered EMs can be enssured by strengthening compounding services, and prioritizing registration of age-appropriate formulations. Availability of another 39 (21.7%) such medicines can be ensured by revising the NEML or the product registrations for the slight differences in their different specifications. The categories showing high proportion of unregistered medicines included anti-Parkinson's medicines (100%), antidotes and other substances used in poisoning (60%), diuretics (47%), anticonvulsants/antiepileptics (42%), hormones and other endocrine medicines and contraceptives (38%), medicines for mental and behavioral disorders (30%), anti-infectives (27%), medicines for pain and palliative care (26%), medicines for neonatal care (25%), medicines for diseases of joint (25%), gastrointestinal medicines (24%) and cardiovascular medicines (15%).<h4>Conclusion</h4>The study shows the absence of registration status of a significant number of EMs in Pakistan. This could be major barrier in their access. Strategies are needed to strengthen the processes of their registration on priority basis.
format Article
id doaj-art-d945d1d5707a4aa688d99e3dfd1e4877
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-d945d1d5707a4aa688d99e3dfd1e48772025-08-20T02:01:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01167e025388010.1371/journal.pone.0253880Availability of essential medicines in Pakistan-A comprehensive document analysis.Sunaina RafiHuma RasheedMuhammad UsmanHafiz Awais NawazSyed Muneeb AnjumMamoona ChaudhryZaheer-Ud-Din Babar<h4>Introduction</h4>Access to essential medicines (EMs) is a basic human right. Non-availability and shortages of EMs are reported for Pakistan but there is insufficient data to define the nature and magnitude of this problem. The current study is designed to systematically analyze the medicines included in the National Essential Medicines List (NEML) for their availability through comprehensive document analysis.<h4>Methods</h4>An expanded list of medicinal items was developed using the NEML of Pakistan (2018) to enlist individual medicines with their specifications. Registration status of the medicines was searched using three publicly accessible information sources; Pharmaguide 25th Edition, 2018-19, the on-line Drug Information System, and the Mobile Application Pharmapedia followed by a later 3-step validation of the data. The unregistered EMs were then further categorized into three subgroups in accordance with their possible remedial strategies.<h4>Findings</h4>The 19 studied categories comprised 690 EMs and it was found that 179 (26%) of these EMs don not have a registration status. However, it was also identified that the availability of 47 (26.2%) out of 179 unregistered EMs can be enssured by strengthening compounding services, and prioritizing registration of age-appropriate formulations. Availability of another 39 (21.7%) such medicines can be ensured by revising the NEML or the product registrations for the slight differences in their different specifications. The categories showing high proportion of unregistered medicines included anti-Parkinson's medicines (100%), antidotes and other substances used in poisoning (60%), diuretics (47%), anticonvulsants/antiepileptics (42%), hormones and other endocrine medicines and contraceptives (38%), medicines for mental and behavioral disorders (30%), anti-infectives (27%), medicines for pain and palliative care (26%), medicines for neonatal care (25%), medicines for diseases of joint (25%), gastrointestinal medicines (24%) and cardiovascular medicines (15%).<h4>Conclusion</h4>The study shows the absence of registration status of a significant number of EMs in Pakistan. This could be major barrier in their access. Strategies are needed to strengthen the processes of their registration on priority basis.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253880&type=printable
spellingShingle Sunaina Rafi
Huma Rasheed
Muhammad Usman
Hafiz Awais Nawaz
Syed Muneeb Anjum
Mamoona Chaudhry
Zaheer-Ud-Din Babar
Availability of essential medicines in Pakistan-A comprehensive document analysis.
PLoS ONE
title Availability of essential medicines in Pakistan-A comprehensive document analysis.
title_full Availability of essential medicines in Pakistan-A comprehensive document analysis.
title_fullStr Availability of essential medicines in Pakistan-A comprehensive document analysis.
title_full_unstemmed Availability of essential medicines in Pakistan-A comprehensive document analysis.
title_short Availability of essential medicines in Pakistan-A comprehensive document analysis.
title_sort availability of essential medicines in pakistan a comprehensive document analysis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253880&type=printable
work_keys_str_mv AT sunainarafi availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis
AT humarasheed availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis
AT muhammadusman availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis
AT hafizawaisnawaz availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis
AT syedmuneebanjum availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis
AT mamoonachaudhry availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis
AT zaheeruddinbabar availabilityofessentialmedicinesinpakistanacomprehensivedocumentanalysis